沙特人口中异性COPD的患病率和临床结果:一项回顾性研究
Fareed Alshehri1, Muath Alghamdi1, Fatinah A Aloqabi1
1Department of Medicine, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Saudi journal of medicine & medical sciences
|February 12, 2025
概括
在沙特患者慢性阻塞性肺病 (COPD),eosinophilic COPD没有与恶化的风险增加相关. 这一发现表明,乙素细胞计数可能不是该人群中COPD恶化的关键预测指标.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 乙酸性慢性阻塞性肺病 (COPD) 是一种表型的COPD,其特征是血中乙酸细胞数量升高.
- 了解异性慢性肺炎的临床意义对于优化患者管理和预测结果至关重要.
研究的目的:
- 为了评估沙特人口中异性COPD的患病率.
- 为了研究乙性COPD与基线特征,临床结果,恶化风险和当前的管理策略之间的相关性.
主要方法:
- 一个回顾性单中心研究,涉及156名被诊断患有COPD的患者.
- 根据血液中乙细胞的数量,患者被分为乙性COPD (≥300细胞/μl) 和非乙性COPD (<300细胞/μl) 组.
- 分析了人口统计,并发症,肺功能 (FEV1,FEV1/FVC),COPD严重程度和恶化史的数据.
主要成果:
- 根据年龄,性别,吸烟状况,并发性疾病,肺功能或COPD严重程度,在eosinophilic和non-eosinophilicCOPD组之间没有发现显著差异.
- 两组之间恶化率,急诊室访问,住院和重症监护室入院情况都相似.
- 虽然三重疗法与更高的恶化风险有关,但eosinophilic表型本身并不是恶化的显著独立预测因素.
结论:
- 在研究的沙特人口中,乙性COPD的患病率被发现是相当大的.
- 在这个队列中,埃索诺菲尔性COPD与恶化风险增加或临床结果较差之间没有显著的关联.
- 在沙特患者中,血中乙氨基酸细胞计数可能不是COPD恶化的可靠独立预测指标.
更多相关视频
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
227
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
227
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K